Time to boycott Oxford Global meetings due to blatant sexism

I don't even know what to say or do about this it is so stunningly pathetic.  I saw this Tweet earlier in the day:

Oxford Global’s Pharmaceutical IT Congress: All 38 speakers male! (it seems)
http://t.co/ctu18mKLAw
@phylogenomics @GenderAvenger #YAMMM

— Elisabeth Bik (@MicrobiomDigest) May 13, 2015

I figured even in an era of blatant sexism in science, this must be a mistake right?  How could there be a conference with 38 male speakers and 0 female speakers.  So I went to the site: Who is Speaking – Oxford Global's 13th Pharmaceutical IT Congress, September 2015.  And, well, as far as I can tell Elisabeth Bik has the numbers right.  (See a list at the end of this post).  They even have a running slideshow of the speakers faces.

This is even worse than the 25:1 ratio of the qBio meeting I lost it over a few years ago.  I have never seen anything like this. I note - a 38:0 ratio is nearly impossible by chance in any field and I think pretty clearly an indication of massive bias of some kind.

I note - this is not the first case of a mostly male meeting from Oxford Global.  See for example:
Oxford Global Sequencing Meetings: Where MEN Tell You About Sequencing #YAMMM

I think it is time to just boycott meetings meetings from Oxford Global.  The only way they will change is if people stop speaking at or going to their meetings.  So please - stop going to their meetings.  Stop speaking at their meetings.

Speakers 2015:

• Sebastien Lefebvre 
  Director Data Engineering and Technology – Global Data Office, Biogen Idec
• Uwe Barlage
  EDC Project Leader, Bayer Healthcare
• Marc Berger
  Vice President, Real World Data and Analytics, Pfizer
• Michael Braxenthaler
  Pharma Research and Early Development Informatics, Global Head Strategic Alliances, Roche, & President, Pistoia Alliance
• Arnaub Chatterjee
  Associate Director - Data Science, Insights and Partnerships, Merck
• James Connelly
  Global Head, Research Data Management, Sanofi
• Jos Echelpoels
  Director IT, Regional Initiatives, Janssen
• Brian Ellerman
  ‎Head of Technology Scouting and Information Science Innovation, Sanofi
• Peter Elsig Raun
  Director & Head Business Analysis, Lundbeck
• Dimitrios Georgiopoulos
  Chief Scientific Officer UK, Novartis
• Charles Gerrits
  Vice President, Innovative Patient-Centric Endpoints and Solutions, Sanofi
• Yike Guo
  Professor of Computing Science, Imperial College London and Chief Technology Officer, tranSMART Foundation
• Sergio H. Rotstein
  Director, Research Business Technology, Pfizer
• Juergen Hammer
  Global Head Data Science, Center Head Pharma Research and Early Development Informatics, Roche
• Jan Hauss
  Head Central Analytics Informatics, Merck
• Athula Herath
  Statistical Director, Translational Sciences, MedImmune
• Nigel Hughes
  Director Integrative Healthcare Informatics, Janssen Research and Development
• Michael Hvalsøe Brinkløv
  BI Architect, IT Platforms & Infrastructure, Lundbeck
• Robert J. Boland
  Senior Manager, Translational Informatics & External Innovation R&D IT, Janssen
• Adrian Jones
  Associate Director, Business Intelligence Systems, Astellas
• Srivatsan Krishnan
  Director and Head of R&D Operations and IT, Bristol-Myers Squibb
• Philippe Marc
  Global Head of Preclinical Informatics, Novartis Institutes for Biomedical Research
• Dermot McCaul
  Director, Preclinical Development and Biologics IT, Merck
• Pantaleo Nacci
  Head Statistical Safety & Epidemiology/PV, Novartis Vaccine and Diagnostics Srl (a GSK company)
• Gerhard Noelken
  Global Business IT Lead for Pharmaceutical Science, Pfizer WRD
• Emmanuel Pham
  VP Biométrie, Ipsen 
• Andrew Porter
  Director, Enterprise Architecture, Merck
• Gabriele Ricci
  Vice President of TechOpps IT, Shire
• Anthony Rowe
  Director, Translational Informatics and External Innovation, Johnson & Johnson
• Martin Ryzl
  Director, GIC Analytics Platform Engineering, Merck
• Wolfgang Seemann
  Senior Project Manager, Bayer Business Services
• Aziz Sheikh
  Professor of Primary Care Research & Development and Co-Director Center for Population Health Sciences, The University of Edinburgh
• Yan Song
  Associate Director, Bioanalysis Operations, AbbVie
• Devry Spreitzer
  Director, Global Electronic Systems Quality Assurance, Astellas
• Jason Swift
  Head R&D Information UK, AstraZeneca
• Kevin Teburi
  Director – iMed Team Leader, R&D Information, AstraZeneca
• Simon Thornber
  Director, Data Analytics, Informatics and Innovation, GlaxoSmithKline
• Tjeerd Van Staa
  Professor of Health eResearch, University of Manchester

Some past meetings from Oxford Global to consider

http://www.bmsystems.net/download/BioMarkers-BMsystems-conferenceprogramme.pdf

https://web.archive.org/web/20120514151415/http://www.ngsasia-congress.com/

Four simple tools to promote gender balance at conferences - guest post from Julie Pfeiffer @jkpfeiff

Guest post from Julie Pfeiffer.

Julie Pfeiffer
Associate Professor of Microbiology
University of Texas Southwestern Medical Center
https://twitter.com/jkpfeiff
http://www4.utsouthwestern.edu/pfeifferlab/Index/Home.html

---

Four simple tools to promote gender balance at conferences 

1. Know that you are biased. Identify your biases.

We all have biases and many of them are unconscious. You can discover your own biases using online social attitude tests developed by Project Implicit, a non-profit organization affiliated with Harvard University. The Gender-Science Implicit Association Test is particularly relevant here. It turns out that I have moderate bias linking science with males, as well as other biases. Knowing this fact has been extremely important. It is very difficult to alter unconscious bias, but it is easy to understand that you are biased and edit your actions accordingly. For example, if I need to make a list of potential speakers or authors quickly, the list will be of senior men from the United States. The key is to spend time EDITING the list to ensure diversity.

2. Keep track of numbers.

Most individuals in leadership positions are not seeking to exclude women or other groups from plenary talks, career opportunities, etc. Instead, they simply forget to count. They forget to keep track of gender ratio and other types of diversity. They forget to edit. When leaders/organizers have diversity in mind, diversity is relatively easy to achieve. Two examples illustrate this point:

1) Vincent Racaniello is President of the American Society for Virology and his goal was to put together an outstanding and diverse group of plenary speakers for the annual meeting in 2015. He asked for speaker suggestions via emails and Twitter (https://twitter.com/profvrr). He made a list and he edited it. The result? The best representation of female scientists at a conference I have ever seen--- 50% of the plenary speakers at ASV this year are female.



2) The Associate Editors at the Journal of Virology choose topics and authors for short reviews called “Gems”. The goal was to have high diversity in several areas including author gender, author career stage, author location, and topic. To keep ourselves on track to achieve this goal, we included several extra columns in our author/topic spreadsheet: Female? Non-USA location? Junior PI? This simple reminder in the spreadsheet has helped us select relatively diverse authors and topics: ~30% are female, ~30% are Assistant Professors, and ~20% are at institutions outside the United States.

3. Create lists and ask people for suggestions. 


Trying to come up with names of female scientists de novo can be a challenge. A few months ago, Carolyn Coyne, Erica Ollmann-Saphire, and Clodagh O’Shea made a list of as many female virologists as they could. Over wine, they devised a list of 70 names. We have circulated this list to many of our colleagues and tweeted a request to send missing names. The list is now at 349 and is publicly available (please tweet missing names to https://twitter.com/jkpfeiff). It is much easier to think of diverse options for speakers and authors by using a pre-existing list. Virologists with this list can no longer claim that they “couldn’t think of a female speaker”. Each field could benefit from a list like this, which could also include other underrepresented groups. Several of these lists exist, as has been highlighted on this and other blogs.

4. Speak up and enlist the help of supportive senior faculty.

Expressing concern to conference organizers about low speaker diversity can go a long way. While it may be difficult to change the speaker list close to the conference date, mentioning the lack of diversity could change the future landscape of the conference. I have an example from my own experience: I created an international shitstorm that had a great outcome. In year three of my faculty position I was considering whether to attend a major conference, so I checked the speaker list to help make my decision. Zero of 18 plenary speakers were female. I decided not to attend. Instead, I emailed the conference organizer to express my disappointment with the complete lack of female plenary speakers. His response, over several emails, was less than supportive:

“…. Finally, the gender, race, religion has never been, to my opinion, valuable ways to select presenters of scientific works. The selection of the Plenary Lectures has been made by the Organizing Committee, that comprises a woman, based on the topic, then the best possible speaker on the topic…. I am aware of the current debate in our societies about "minimum numbers". I do not think they would help the cause of women in science.”

While this organizer was not supportive or responsive to my speaker suggestions, five senior (famous) faculty members in the field were hyper-supportive. Upon hearing this story, they each contacted the organizer and expressed their concern about the lack of diversity. It was too late to change the program for the conference that year. However, in every subsequent year, the plenary speakers at this conference have included women and other underrepresented groups. So, it’s possible that a simple email from a young scientist can make a difference, particularly with the help of senior faculty.

Today's YAMMM - The British Society for Plant Pathology

Well, this is not the most egregious example of a mostly male meeting but it still has some issues: The BSPP - The British Society for Plant Pathology 2015 meeting.  Nine speakers.  Seven male.  And this in a field with plenty of excellent female researchers.

Cassava brown streak disease
(1) James Legg - IITA Tanzania
(2) Stephan Winter - Leibniz Institute DSMZ Germany
(3) Maruthi Gowda - Natural Resources Institute, University of Greenwich

Late blight
(1) Bill Fry - Cornell University
(2) Sophien Kamoun - Sainsbury Lab, Norwich
(3) Jonathan Jones - Sainsbury Lab, Norwich

Rice blast
(1) Sarah Gurr - University of Exeter
(2) Lauren Ryder - University of Exeter
(3) Thomas Kroj - INRA, Montpellier, France

But the weirdest part --  it says

"This year, the BSPP President, Prof. Gary Foster, has only chosen a few invited speakers on specific diseases, and wishes the remainder of the talks to be selected from offered papers."

So does this mean Prof. Gary Foster just picked all speakers?  If so, perhaps Prof. Gary Foster needs to do a little thinking about his possible biases ...

#YAMMM Alert: Drug Discovery and Therapy World Congress, a meeting made for @realDonaldTrump & other men

Note - see update at bottom of post

Elizabeth Bik sent me a link to this meeintg: DRUG DISCOVERY & THERAPY WORLD CONGRESS 2015 with a comment about the ratio of males to females in the keynote speakers.  And it is painful.  Of the plenary and keynote speakers, 15 are male and 1 is female.  Below I show pics of the plenary and keynote speakers:

Plenary and Keynote Speakers at Drug Discovery and Thearpy World Congress

Female Plenary and Keynote Speakers at Drug Discovery and Thearpy World Congress

Two bonus people who could have been giving keynote talks but who actually are not.

The gender bias at this meeting puts into perspective the push by the NIH to get drug researchers to inlcude more female subjects in their studies.  See for example, Why Are All the Lab Rats Boys? NIH Tells Drug Researchers to Stop Being Sexist Pigs.  Here is a thought, maybe we can get some of these speakers to cancel speaking at the meeting and also maybe we can get nobody to attent the meeting.  Sigh.  Yet another mostly male meeting.  Also known as "YAMMM".

--------------------
UPDATE October 14, 2014.

Well, this is one of the strangest and lamest things I have seen associated with a conference in a while.  Elizabeth Bik just emailed me to show me an invite she received to the "Global Biotechnology Congress 2015."  And here is the bizarre thing.  It is at the same time as the Drug Discovery meeting discussed here.  Same place.  Same speakers.  It is apparently the same meeting with a new name.

Same bad gender ratio of course too.

Did they do this to avoid people discovering my post about the awful gender ratio?  I don't know but seems like it might be so.  What a joke.  Well, I can guarantee people will associated this meeting name with the previous one.  

A distasteful & disgraceful "Are there limits to evolution?" meeting at the University of Cambridge #YAMMM

Well, I saw this Tweet the other day

Another for @phylogenomics's list of YAMMMs (Yet Another Mostly Male Mtg). Ratio = 1F speaker to 23M speakers. http://t.co/qgEfwtBS2B
— Hopi Hoekstra (@hopihoekstra) September 16, 2014

And though there was a bit of a discussion on Twitter I felt I had to follow up with a blog post. When I saw the post I was at a conference (Lake Arrowhead Microbial Genomes) where I could get Twitter access but for some reason very little web access. So I could not dig around until now (I am home). 

This meeting is a complete disgrace and an embarassment for the field of evolutionary biology, for the University of Cambridge which is hosting the meeting, and for the Templeton Foundation which is sponsoring it.

Why do I say this? Well, pretty simple actually. The meeting site lists the Invited Keynote speakers for the meeting.  Notice anything?  How about I help you by bringing all the pictures together.

Notice anything now?  How about I help you some more by masking out the men and not the women.

Impressive no?  25 speakers - 23 of them male.  I guess that means there are no qualified female speakers who coudl discuss something about evolution right?  It would be worth reading "Fewer invited talks bu women in evolutionary biology symposia" to get some context.  What an incredible, disgusting, distasteful and disgraceful meeting.  

I recommend to everyone who was considering going to this meeting - skip it.  Also consider writing to the University of Cambirdge and the Templeton Foundation to express your thoughts about the meeting.  This certainly is a fine example of Yet Another Mostly Male Meeting (YAMMM).  Well, maybe I should word that differently - this is a disgusting example of a YAMMM.  

---

For more on this and related issues

Posts on Women in STEM

Also see

See meeting w/ severely bad speaker gender ratio but don't feel comfortable posting?send me details & I will post phylogenomics@me.com
— Jonathan Eisen (@phylogenomics) September 19, 2014